13F Holdings
中文EN

THC TENET HEALTHCARE CORP

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 70318 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.2%
TTM net income YoY114.1%
TTM EPS YoY133.1%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR83.5%

Margins

Gross margin—
Operating margin24.4%
Net margin13.1%
FCF margin15.0%
EBITDA margin28.4%

Returns

ROE61.3%
ROA9.5%
ROIC (approx.)28.2%
Asset turnover0.73x

Leverage & solvency

Liabilities / assets69.6%
Debt / equity2.43x
Current ratio1.58x
Interest coverage6.61x

Cash quality & payout

Operating cash flow / net income1.46x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue4.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31FY2023*2023-12-31FY2022*2022-12-31FY2021*2021-12-31
Income statement
Revenue$21.31B$20.68B$20.56B$19.17B$19.48B
Operating income$3.51B$5.96B$2.51B$2.33B$2.87B
Interest expense$821.00M$826.00M$901.00M$890.00M$923.00M
Pretax income$2.80B$5.25B$1.62B$1.34B$1.89B
Income tax$433.00M$1.18B$306.00M$344.00M$411.00M
Net income$1.41B$3.20B$611.00M$411.00M$914.00M
EBITDA$4.37B$6.77B$3.38B$3.17B$3.73B
EPS (basic)15.6133.026.013.848.55
EPS (diluted)15.4932.705.713.798.42
Weighted avg. shares (diluted)90.83M97.88M104.80M110.52M108.57M
Balance sheet
Cash & equivalents$2.88B$3.02B$1.23B$858.00M$2.36B
Receivables$2.56B$2.54B$2.91B$2.94B$2.77B
Inventory$348.00M$346.00M$411.00M$405.00M$384.00M
Current assets$7.85B$7.68B$7.17B$5.98B$7.08B
PP&E, net$6.32B$6.05B$6.24B$6.46B$6.43B
Goodwill$11.20B$10.69B$10.31B$10.12B$9.26B
Intangibles$1.35B$1.40B$1.37B$1.42B$1.50B
Total assets$29.68B$28.94B$28.31B$27.16B$27.58B
Current liabilities$4.46B$4.31B$4.76B$4.48B$5.11B
Short-term debt$79.00M$92.00M$120.00M$145.00M$135.00M
Long-term debt$13.09B$13.08B$14.88B$14.93B$15.51B
Total debt$13.17B$13.17B$15.00B$15.08B$15.65B
Total liabilities$20.70B$20.39B$22.80B$22.55B$23.32B
Shareholders' equity$4.22B$4.17B$1.61B$1.14B$1.03B
Net debt$10.29B$10.15B$13.77B$14.22B$13.28B
Cash flow statement
Operating cash flow$3.54B$2.05B$2.37B$1.08B$1.57B
Capital expenditure$1.01B$931.00M$751.00M$762.00M$658.00M
Free cash flow$2.53B$1.12B$1.62B$321.00M$910.00M
Investing cash flow-$1.27B$3.43B-$969.00M-$808.00M-$714.00M
Financing cash flow-$2.40B-$3.69B-$1.03B-$1.78B-$936.00M
Depreciation & amortization$863.00M$818.00M$870.00M$841.00M$855.00M
Stock-based compensation$104.00M$67.00M$66.00M$56.00M$56.00M
Share buybacks$1.39B$672.00M$200.00M$250.00M$0

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.